DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Bromhexine

Bromhexine

  • 2020 Equine Prohibited Substances List CONTROLLED MEDICATION

    2020 Equine Prohibited Substances List CONTROLLED MEDICATION

  • National OTC Medicines List

    National OTC Medicines List

  • Mucoactive Agents for Airway Mucus Hypersecretory Diseases

    Mucoactive Agents for Airway Mucus Hypersecretory Diseases

  • Bromhexine Hydrochloride

    Bromhexine Hydrochloride

  • List Over Prohibited Substances and Withdrawal Times, Valid from January 1St, 2016 A. LIST of PROHIBITED SUBSTANCES

    List Over Prohibited Substances and Withdrawal Times, Valid from January 1St, 2016 A. LIST of PROHIBITED SUBSTANCES

  • Bromhexine Hydrochloride: Potential Approach to Prevent Or Treat Early Stage COVID-19

    Bromhexine Hydrochloride: Potential Approach to Prevent Or Treat Early Stage COVID-19

  • PHARMACEUTICAL APPENDIX to the TARIFF SCHEDULE 2 Table 1

    PHARMACEUTICAL APPENDIX to the TARIFF SCHEDULE 2 Table 1

  • Overview of Planned Or Ongoing Studies of Drugs for the Treatment of COVID-19

    Overview of Planned Or Ongoing Studies of Drugs for the Treatment of COVID-19

  • Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

    Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

  • Current Pharma Research ISSN-2230-7842 CODEN-CPRUE6

    Current Pharma Research ISSN-2230-7842 CODEN-CPRUE6

  • Bisolvon Chesty Forte Oral Contains Bromhexine Hydrochloride 8 Mg

    Bisolvon Chesty Forte Oral Contains Bromhexine Hydrochloride 8 Mg

  • Antibiotics, Expectorants, and Cough Suppressants

    Antibiotics, Expectorants, and Cough Suppressants

  • Review of Cough and Cold Medicines in Children

    Review of Cough and Cold Medicines in Children

  • Mucoactive Agents in the Therapy of Upper Respiratory Airways Infections

    Mucoactive Agents in the Therapy of Upper Respiratory Airways Infections

  • I (Acts Whose Publication Is Obligatory) COMMISSION

    I (Acts Whose Publication Is Obligatory) COMMISSION

  • Chapter 6 |Management of Morbidity

    Chapter 6 |Management of Morbidity

  • Drug Utilisation of Codeine in Children: EMA Analyses of the Health Improvement Network and of the IMS Health German Databases

    Drug Utilisation of Codeine in Children: EMA Analyses of the Health Improvement Network and of the IMS Health German Databases

  • Review of Existing Classification Efforts

    Review of Existing Classification Efforts

Top View
  • Prescription of Codeine in Young Infants
  • Methylnaltrexone Bromide
  • Electronic Supplementary Material
  • Antitussives
  • Reseptregisteret 2014–2018 the Norwegian Prescription Database 2014–2018
  • Drug/Substance Trade Name(S)
  • Medicines (Prescription Only) (Jersey) Order 1997
  • Potential Role of Antioxidant and Anti-Inflammatory Therapies
  • The Coughing Dog
  • SARS-Cov-2 Entry Inhibitors: Small Molecules and Peptides Targeting Virus Or Host Cells
  • Analysis of the Evidence of Efficacy and Safety of Over-The-Counter Cough Medications Registered in Brazil
  • Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
  • A Pharmaceutical Composition Comprising a Menthane Carboxylic Acid Amide
  • 2019 Equine Prohibited Substances List
  • Benzonatate Has Local Anaesthetic Adverse Effects Acidosis
  • CHAPTER 9 Therapeutic Agents
  • Validated RP-HPLC Method for Determination of Bromhexine Hcl, Chlorpheniramine Maleate, Dextromethorphan Hbr and Guaiphenesin in Pharmaceutical Dosage Forms
  • Management of Drug Overdose and Poisoning


© 2024 Docslib.org    Feedback